Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital — Washington D.C., District of Columbia

Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital has participated in 1 clinical trials.

Therapeutic areas: Malignancies.

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital?

Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital conducted?

Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital has 1 clinical trials on record. Their work covers Malignancies.

Is Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital accredited by Crixeo Health?

Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lombardi Comprehensive Cancer Center - MedStar Georgetown University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.